$47.05
-1.61-3.31%
Last update: Aug 26, 12:45 PM
Novo Nordisk AS
NVONYSE
Novo Nordisk Earnings & Forecasts
Novo Nordisk (NVO) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Novo Nordisk Guidance
Novo Nordisk (NVO) last issued guidance on May 6, 2026 for fiscal year 2026. The company guided revenue in the range of $42.39B - $46.24B for the period.
Compared to prior guidance, Novo Nordisk raised its revenue forecast from a prior range of $40.46B - $44.32B.
Novo Nordisk has issued 15 guidance updates between November 2, 2022 and May 6, 2026. During this period, the company raised its outlook 11 times and lowered it 2 times, providing investors with insight into management's evolving expectations.
Recent Earnings Results
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $0.81 | $0.87 | $0.89 | $0.77 |
| Actual | $0.96 | $1.04 | $1.00 | $1.03 |
| Surprise | +18.6% | +19.3% | +12.4% | +33.4% |
| Revenue | ||||
| Estimate | $11.35B | $11.13B | $12.08B | $11.88B |
| Actual | $12.21B | $15.17B | $12.34B | $11.74B |
| Surprise | +7.57% | +36.3% | +2.11% | -1.14% |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $0.80 | $0.73 | $0.91 | $0.89 |
| Revenue | ||||
| Consensus | $11.29B | $11.98B | — | — |
